Minamestane

CAS No. 105051-87-4

Minamestane( —— )

Catalog No. M36378 CAS No. 105051-87-4

Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 304 In Stock
10MG 447 In Stock
25MG 733 In Stock
50MG 1004 In Stock
100MG 1358 In Stock
200MG Get Quote In Stock
500MG 2716 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Minamestane
  • Note
    Research use only, not for human use.
  • Brief Description
    Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
  • Description
    Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Aromatase
  • Recptor
    Aromatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    105051-87-4
  • Formula Weight
    297.39
  • Molecular Formula
    C19H23NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)C(=O)CC4)[H])(C=CC1=C(N)C(=O)C=C2)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Testolactone

    Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?

  • Formestane

    Formestane was the first selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast Y in post-menopausal women.

  • 3,4-Dimethoxyhydroci...

    It is an organic compunds with molecular fomula C11H14O4.